Sort
21,453 grants matching “tuberculosis”
Clinical Research Products Management Center (CRPMC)
$6,403,977Beth Trainor-Mobley · Fisher Bioservices, Inc. · N01 · FY2014 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$6,377,610Herbert W Virgin · Washington University · U19 · FY2014 · AI
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3
$6,366,878Robert W. Coombs · Brigham And Women'S Hospital · UM1 · FY2014 · AI
Southwest National Primate Research Center
$6,344,074Kenneth Parkhurst Trevett · Texas Biomedical Research Institute · P51 · FY2008 · RR
Terry Beirn CPCRA Clinical Trials Unit
$6,340,355Virginia Kan · George Washington University · UM1 · FY2019 · AI
Simian Vaccine Evaluation Unit (SVEU)
$6,297,694Phillip Markham · Advanced Bioscience Laboratories, Inc. · N01 · FY2012 · AI
Tri-Institutional TB Research Unit: Persistence and Latency
$6,284,115Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2014 · AI
HIV Vaccines Clinical Trials Network Leadership and Operations Center
$6,272,147Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2022 · AI
Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU)
$6,259,351Raphael Dolin · Beth Israel Deaconess Medical Center · UM1 · FY2019 · AI
Clinical Research Products Management Center (CRPMC)
$6,234,701Beth Trainor-Mobley · Fisher Bioservices, Inc. · N01 · FY2013 · AI
KARABELO Clinical Trials Unit for NIAID Networks
$6,186,290Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2020 · AI
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$6,064,003Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2019 · AI
ADVANCING A PROMISING TUBERCULOSIS VACCINE CANDIDATE: MTBVAC
$6,059,848International Aids Vaccine Initiative Inc. · · FY2017 · Defense Health Agency
Southwest National Primate Research Center
$6,049,676John C. Kerr · Texas Biomedical Research Institute · P51 · FY2006 · RR
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
$6,040,432Keri Hammel · The Emmes Company, Llc · N01 · FY2016 · EY
Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb.
$6,025,401Nader Fotouhi · Global Alliance For Tb Drug Development · U19 · FY2021 · AI
Adjuvant Development Program
$6,010,421Rhea Coler · Access To Advanced Health Institute · N01 · FY2011 · AI
Southwest National Primate Research Center
$6,004,828Southwest Foundation For Biomedical Res · P51 · FY2004 · RR
DMID CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT
$6,000,000Melynda Holmes · Technical Resources International, Inc. · N01 · FY2010 · AI
Regional Prospective Observational Research in Tuberculosis (RePORT) India Consortium (RePORT-India)
$6,000,000Michael Dignam · National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI
Regional Prospective Observational Research for Tuberculosis (RePORT) South Africa Consortium (RePORT- South Africa)
$6,000,000Michael Dignam · National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI
Genomic Sequencing Center for Infectious Diseases
$6,000,000Bruce Birren · Broad Institute, Inc. · N01 · FY2012 · AI
Integrated discovery and development of innovative TB Diagnostics
$5,956,642Megan B Murray · Harvard Medical School · U19 · FY2014 · AI
Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb.
$5,956,416Nader Fotouhi · Global Alliance For Tb Drug Development · U19 · FY2022 · AI
Integrated discovery and development of innovative TB Diagnostics
$5,950,279Megan B Murray · Harvard Medical School · U19 · FY2017 · AI